Torbjörn Ogéus discusses the next frontier in regenerative medicine for osteoarthritis, from innovation to clinical validation and standard of care ...
The final, formatted version of the article will be published soon. Microfracture (MF) often yields regenerated cartilage that resembles scar tissue and is prone to rapid deterioration. This outcome ...
Cartilage damage has long been a challenge in regenerative medicine research, due to the avascular nature of cartilage tissue and its intrinsically limited reparative capacity. In recent years, more ...
Dr. Charles Schlesinger, the vice president of clinical development at Impladent, shared at the Chicago Dental Society 2026 Midwinter Meeting that bioactive crystal technology (BCT) offers predictable ...
Dr. Reske has proven leadership in clinical development and regulatory affairs following key role in FDA approval of cartilage repair product Agili-C leading to CartiHeal's $330 million acquisition ...
Dr. Reske has proven leadership in clinical development and regulatory affairs following key role in FDA approval of cartilage repair product Agili-C leading to CartiHeal's $330 million acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results